Frankfurt - Delayed Quote EUR

MicroPort CardioFlow Medtech Corporation (72X.F)

0.1100 +0.0275 (+33.33%)
At close: May 28 at 8:17 AM GMT+2
Currency in CNY All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
336,215.0000
336,215.0000
251,026.0000
200,813.0000
103,934.0000
--
Cost of Revenue
106,284.0000
106,284.0000
88,896.0000
82,112.0000
58,554.0000
--
Gross Profit
229,931.0000
229,931.0000
162,130.0000
118,701.0000
45,380.0000
--
Operating Expense
581,571.0000
581,571.0000
494,008.0000
321,904.0000
230,753.0000
--
Operating Income
-351,640.0000
-351,640.0000
-331,878.0000
-203,203.0000
-185,373.0000
--
Net Non Operating Interest Income Expense
82,397.0000
82,397.0000
33,231.0000
4,810.0000
-141,083.0000
--
Pretax Income
-463,582.0000
-463,582.0000
-451,299.0000
-182,651.0000
-398,087.0000
--
Tax Provision
7,952.0000
7,952.0000
3,096.0000
613.0000
--
--
Net Income Common Stockholders
-471,534.0000
-471,534.0000
-454,395.0000
-183,264.0000
-398,087.0000
--
Diluted NI Available to Com Stockholders
-471,534.0000
-471,534.0000
-454,395.0000
-183,264.0000
-398,087.0000
--
Basic EPS
-0.20
-0.20
-0.19
-0.08
-0.17
--
Diluted EPS
-0.20
-0.20
-0.19
-0.08
-0.17
--
Basic Average Shares
2,362,906.0000
2,362,906.0000
2,365,637.0000
2,331,301.0000
2,366,167.0200
--
Diluted Average Shares
2,362,906.0000
2,362,906.0000
2,365,637.0000
2,331,301.0000
2,366,167.0200
--
Total Operating Income as Reported
-313,651.0000
-313,651.0000
-376,579.0000
-159,238.0000
-252,496.0000
--
Rent Expense Supplemental
--
--
--
--
--
1,729.0000
Total Expenses
687,855.0000
687,855.0000
582,904.0000
404,016.0000
289,307.0000
--
Net Income from Continuing & Discontinued Operation
-471,534.0000
-471,534.0000
-454,395.0000
-183,264.0000
-398,087.0000
--
Normalized Income
-372,951.7500
-372,951.7500
-390,840.7500
-200,401.5000
-333,344.0000
--
Interest Income
86,544.0000
86,544.0000
38,642.0000
24,711.0000
5,224.0000
--
Interest Expense
3,915.0000
3,915.0000
5,188.0000
19,639.0000
146,150.0000
--
Net Interest Income
82,397.0000
82,397.0000
33,231.0000
4,810.0000
-141,083.0000
--
EBIT
-459,667.0000
-459,667.0000
-446,111.0000
-163,012.0000
-251,937.0000
--
EBITDA
-386,049.0000
-386,049.0000
-367,896.0000
-118,589.0000
-227,434.0000
--
Reconciled Cost of Revenue
106,284.0000
106,284.0000
88,896.0000
82,112.0000
58,554.0000
--
Reconciled Depreciation
73,618.0000
73,618.0000
78,215.0000
44,423.0000
24,503.0000
--
Net Income from Continuing Operation Net Minority Interest
-471,534.0000
-471,534.0000
-454,395.0000
-183,264.0000
-398,087.0000
--
Total Unusual Items Excluding Goodwill
-131,443.0000
-131,443.0000
-84,739.0000
22,850.0000
-64,743.0000
--
Total Unusual Items
-131,443.0000
-131,443.0000
-84,739.0000
22,850.0000
-64,743.0000
--
Normalized EBITDA
-254,606.0000
-254,606.0000
-283,157.0000
-141,439.0000
-162,691.0000
--
Tax Rate for Calcs
0.0003
0.0003
0.0003
0.0003
--
--
Tax Effect of Unusual Items
-32,860.7500
-32,860.7500
-21,184.7500
5,712.5000
--
--
12/31/2019 - 2/8/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade